Literature DB >> 12077335

TRRAP-dependent and TRRAP-independent transcriptional activation by Myc family oncoproteins.

Mikhail A Nikiforov1, Sanjay Chandriani, Jeonghyeon Park, Iulia Kotenko, Dina Matheos, Anna Johnsson, Steven B McMahon, Michael D Cole.   

Abstract

We demonstrate that transformation-transactivation domain-associated protein (TRRAP) binding and the recruitment of histone H3 and H4 acetyltransferase activities are required for the transactivation of a silent telomerase reverse transcriptase (TERT) gene in exponentially growing human fibroblasts by c-Myc or N-Myc protein. However, recruitment of TRRAP by c- or N-Myc is dispensable for the partial induction of several basally expressed genes in exponentially growing primary and immortalized fibroblasts. Furthermore, recruitment of TRRAP is required for c-Myc- or N-Myc-mediated oncogenic transformation but not for the partial restoration of the growth defect in myc-null fibroblasts. A segment of the adenovirus E1A protein fused to a transformation-defective N-Myc protein carrying a small deletion in the transactivation domain specifically restores interaction with TRRAP, activates the silent TERT gene, induces acetylation of histones H3 and H4 at the TERT promoter, and transforms primary cells. Accordingly, wild-type L-Myc is much less efficient in TRRAP binding, activation of the silent TERT gene, and transformation of primary fibroblasts. Nevertheless, L-Myc is a potent activator of several basally expressed genes and can fully restore the growth defect of myc-null cells. These results suggest a differential requirement for TRRAP for several Myc-mediated activities.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12077335      PMCID: PMC139788          DOI: 10.1128/MCB.22.14.5054-5063.2002

Source DB:  PubMed          Journal:  Mol Cell Biol        ISSN: 0270-7306            Impact factor:   4.272


  52 in total

Review 1.  A critical role for telomeres in suppressing and facilitating carcinogenesis.

Authors:  S E Artandi; R A DePinho
Journal:  Curr Opin Genet Dev       Date:  2000-02       Impact factor: 5.578

2.  Loss of N-myc function results in embryonic lethality and failure of the epithelial component of the embryo to develop.

Authors:  B R Stanton; A S Perkins; L Tessarollo; D A Sassoon; L F Parada
Journal:  Genes Dev       Date:  1992-12       Impact factor: 11.361

3.  Definition of the activities and properties of c-myc required to inhibit cell differentiation.

Authors:  S O Freytag; C V Dang; W M Lee
Journal:  Cell Growth Differ       Date:  1990-07

4.  Induction of apoptosis in fibroblasts by c-myc protein.

Authors:  G I Evan; A H Wyllie; C S Gilbert; T D Littlewood; H Land; M Brooks; C M Waters; L Z Penn; D C Hancock
Journal:  Cell       Date:  1992-04-03       Impact factor: 41.582

5.  Complementation of transforming domains in E1a/myc chimaeras.

Authors:  R Ralston
Journal:  Nature       Date:  1991-10-31       Impact factor: 49.962

Review 6.  Quantitative analysis of regions of adenovirus E1A products involved in interactions with cellular proteins.

Authors:  D Barbeau; R C Marcellus; S Bacchetti; S T Bayley; P E Branton
Journal:  Biochem Cell Biol       Date:  1992 Oct-Nov       Impact factor: 3.626

7.  The essential cofactor TRRAP recruits the histone acetyltransferase hGCN5 to c-Myc.

Authors:  S B McMahon; M A Wood; M D Cole
Journal:  Mol Cell Biol       Date:  2000-01       Impact factor: 4.272

8.  Activation domains of L-Myc and c-Myc determine their transforming potencies in rat embryo cells.

Authors:  J Barrett; M J Birrer; G J Kato; H Dosaka-Akita; C V Dang
Journal:  Mol Cell Biol       Date:  1992-07       Impact factor: 4.272

9.  A null c-myc mutation causes lethality before 10.5 days of gestation in homozygotes and reduced fertility in heterozygous female mice.

Authors:  A C Davis; M Wims; G D Spotts; S R Hann; A Bradley
Journal:  Genes Dev       Date:  1993-04       Impact factor: 11.361

10.  L-myc cooperates with ras to transform primary rat embryo fibroblasts.

Authors:  M J Birrer; S Segal; J S DeGreve; F Kaye; E A Sausville; J D Minna
Journal:  Mol Cell Biol       Date:  1988-06       Impact factor: 4.272

View more
  50 in total

1.  MYC recruits the TIP60 histone acetyltransferase complex to chromatin.

Authors:  Scott R Frank; Tiziana Parisi; Stefan Taubert; Paula Fernandez; Miriam Fuchs; Ho-Man Chan; David M Livingston; Bruno Amati
Journal:  EMBO Rep       Date:  2003-06       Impact factor: 8.807

2.  Myc-induced proliferation and transformation require Akt-mediated phosphorylation of FoxO proteins.

Authors:  Caroline Bouchard; Judith Marquardt; Alexandra Brás; René H Medema; Martin Eilers
Journal:  EMBO J       Date:  2004-07-08       Impact factor: 11.598

3.  The Cellular Protein Complex Associated with a Transforming Region of E1A Contains c-MYC.

Authors:  S Vijayalingam; T Subramanian; Ling-Jun Zhao; G Chinnadurai
Journal:  J Virol       Date:  2015-11-11       Impact factor: 5.103

4.  GAS41 is required for repression of the p53 tumor suppressor pathway during normal cellular proliferation.

Authors:  Jeong Hyeon Park; Robert G Roeder
Journal:  Mol Cell Biol       Date:  2006-06       Impact factor: 4.272

5.  The double bromodomain proteins Brd2 and Brd3 couple histone acetylation to transcription.

Authors:  Gary LeRoy; Brenden Rickards; S J Flint
Journal:  Mol Cell       Date:  2008-04-11       Impact factor: 17.970

6.  Heterochromatin protein 1 is extensively decorated with histone code-like post-translational modifications.

Authors:  Gary LeRoy; John T Weston; Barry M Zee; Nicolas L Young; Mariana D Plazas-Mayorca; Benjamin A Garcia
Journal:  Mol Cell Proteomics       Date:  2009-06-30       Impact factor: 5.911

7.  Strategic attack on host cell gene expression during adenovirus infection.

Authors:  Hongxing Zhao; Fredrik Granberg; Ludmila Elfineh; Ulf Pettersson; Catharina Svensson
Journal:  J Virol       Date:  2003-10       Impact factor: 5.103

8.  The tumor suppressor protein HBP1 is a novel c-myc-binding protein that negatively regulates c-myc transcriptional activity.

Authors:  Julienne R Escamilla-Powers; Colin J Daniel; Amy Farrell; Karyn Taylor; Xiaoli Zhang; Sarah Byers; Rosalie Sears
Journal:  J Biol Chem       Date:  2009-12-11       Impact factor: 5.157

9.  C-MYC overexpression is required for continuous suppression of oncogene-induced senescence in melanoma cells.

Authors:  D Zhuang; S Mannava; V Grachtchouk; W-H Tang; S Patil; J A Wawrzyniak; A E Berman; T J Giordano; E V Prochownik; M S Soengas; M A Nikiforov
Journal:  Oncogene       Date:  2008-08-04       Impact factor: 9.867

10.  A core MYC gene expression signature is prominent in basal-like breast cancer but only partially overlaps the core serum response.

Authors:  Sanjay Chandriani; Eirik Frengen; Victoria H Cowling; Sarah A Pendergrass; Charles M Perou; Michael L Whitfield; Michael D Cole
Journal:  PLoS One       Date:  2009-08-19       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.